The controlled multi-centre, randomised, prospective trial is investigating the therapy in kidney transplant recipients.

Kamada begins patient enrolment in an investigator-initiated clinical trial of Cytogam to prevent cytomegalovirus in kidney transplantation: Rehovot, Israel Thursday, November 6, ...

Declining immune responsiveness with age may be driven by changes in immune cells — not by inflammation, as previously ...

Doctors in Belgium met with a real head-scratcher when an 83-year-old married man came in with a rare form of secondary ...

Analysts are expecting Moderna to report revenue of $880 million in the third quarter, according to FactSet. The consensus ...

Our latest Focus Issue looks at what we’ve learnt over the past decade and what’s next for the field of trained immunity.